Application 022200
- Type
- NDA
- Sponsor
- ASTRAZENECA AB
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BYDUREON | EXENATIDE SYNTHETIC | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 2MG/VIAL | Yes | Yes |
| 002 | BYDUREON PEN | EXENATIDE SYNTHETIC | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 2MG | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0310-6520 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6520 | BYDUREON | exenatide | AstraZeneca Pharmaceutica | NDA | Current |
| 0310-6520 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6520 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceutica | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-6530 | BYDUREON | exenatide | AstraZeneca Pharmaceuticals LP | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82384 | SUPPL | 2025-06-02 |
| 82383 | SUPPL | 2025-06-02 |
| 82343 | SUPPL | 2025-05-29 |
| 80119 | SUPPL | 2024-11-05 |
| 80105 | SUPPL | 2024-11-04 |
| 73014 | SUPPL | 2022-12-23 |
| 73013 | SUPPL | 2022-12-23 |
| 72993 | SUPPL | 2022-12-22 |
| 71642 | SUPPL | 2022-07-27 |
| 71641 | SUPPL | 2022-07-27 |
| 71637 | SUPPL | 2022-07-27 |
| 71323 | SUPPL | 2022-06-15 |
| 71322 | SUPPL | 2022-06-15 |
| 71281 | SUPPL | 2022-06-13 |
| 68178 | SUPPL | 2021-07-26 |
| 68166 | SUPPL | 2021-07-22 |
| 62013 | SUPPL | 2020-03-03 |
| 62003 | SUPPL | 2020-03-02 |
| 57725 | SUPPL | 2019-02-21 |
| 57712 | SUPPL | 2019-02-20 |
| 56237 | SUPPL | 2018-11-01 |
| 53592 | SUPPL | 2018-04-03 |
| 53591 | SUPPL | 2018-04-03 |
| 50154 | SUPPL | 2017-10-24 |
| 50143 | SUPPL | 2017-10-23 |
| 38373 | SUPPL | 2015-10-07 |
| 38372 | SUPPL | 2015-10-07 |
| 17074 | SUPPL | 2015-10-07 |
| 38371 | SUPPL | 2015-10-06 |
| 29395 | SUPPL | 2015-09-28 |
| 7035 | SUPPL | 2015-09-28 |
| 7034 | SUPPL | 2015-09-28 |
| 7033 | SUPPL | 2015-09-28 |
| 38374 | SUPPL | 2015-09-23 |
| 7037 | SUPPL | 2015-09-22 |
| 7031 | SUPPL | 2015-05-05 |
| 17075 | SUPPL | 2015-03-27 |
| 7036 | SUPPL | 2015-03-11 |
| 17073 | SUPPL | 2015-03-09 |
| 29394 | SUPPL | 2015-03-06 |
| 42446 | SUPPL | 2014-08-05 |
| 38370 | SUPPL | 2014-05-28 |
| 17072 | SUPPL | 2014-05-28 |
| 29393 | SUPPL | 2014-05-27 |
| 7032 | SUPPL | 2014-05-27 |
| 7030 | SUPPL | 2014-03-05 |
| 17071 | SUPPL | 2014-03-04 |
| 44698 | ORIG | 2012-06-12 |
| 42445 | ORIG | 2012-06-12 |
| 17070 | ORIG | 2012-01-27 |
| 7029 | ORIG | 2012-01-27 |